Alzheimer’s disease (AD) is a progressive neurodegenerative disorder defined biologically by abnormal accumulation of β-amyloid (Aβ), tau, and clinically by insidious declines in memory, executive, and behavioral changes that can impair daily life [1]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.